Market Access and Reimbursement for Orphan Drugs & Rare Diseases Conference

Hear from industry leaders on gaining comprehension of patient advocacy, payer and specialty pharmacy groups to access orphan drug populations.

This conference comes at a pivotal time when product patents are coming to an end and companies are looking to replenish their pipelines. Attending this premier conference will give you the opportunity to discuss critical issues, such as the Orphan Drug Act, while benchmarking your market access techniques in order to enhance and grow existing orphan drug portfolios.

Attending this conference will enable you to:
· Discover the incentives of the Orphan Drug Act and other FDA programs for rare diseases.
· Understand the insights, concerns and processes of specialty pharmacies and payers regarding orphan drugs.
· Utilize data and health technology assessment to reduce costs and increase perceived value of orphan drugs

This is not a trade show; our conference is targeted at a focused group of senior level executives to maintain an intimate atmosphere for the delegates and speakers. Since this is not a vendor driven conference, the higher level focus allows the delegates to network with speakers and peers.

Join our Life Sciences/Pharma LinkedIn Group ( be able to start networking with your peers before and after the conference.

For more information please email or go to